Our Molecular Genetics portfolio provides solutions for all areas of disease, including screening, diagnosis, and monitoring. Through a range of partners, Abacus dx aims to provide Australian and New Zealand laboratories with simple and efficient testing solutions for a range of methods including polymerase chain reaction, next-generation sequencing, and fluorescence in situ hybridisation.
Discover the Invivoscribe control portfolio
Invivoscribe offers an extensive range of General Purpose Reagents (GPRs) and Research Use Only (RUO) controls.
[…]
WHEN TIME MATTERS. THINK BIOCARTIS IDYLLA*. YOUR BIOMARKER TEST RESULTS WITHIN 3 HOURS.
The Idylla™ solution is a revolutionary, fully automated, real-time PCR based molecular testing system designed to offer results in a minimum amount of time.
[…]
Abacus dx are thrilled to announce ZytoVision* received their In Vitro Diagnostics Regulation (IVDR) certification for its selected product portfolio.
[…]
Asuragen’s Precision Oncology Solutions.
Revolutionising Precision Oncology with QuantideX®: Where Sensitivity Meets Scalability
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Within 150 minutes and with less than 2 minutes hands-on time, the fully automated Idylla™ EGFR Mutation Test covers 51 mutations in exons 18–21 in a single cartridge
[…]